Although some degree of phenotypic variability was observed in the CIPA patients with proven NTRK1 mutations, overall the clinical presentation corresponds to a readily recognizable syndrome that is genetically homogenous [12], [13]. Here, NTRK1 is linked to hereditary sensory and autonomic neuropathy type 4.